Mohit Manghnani is an Overnight Newsdesk Manager at Yahoo Finance. He specializes in medicine and healthcare, focusing on various medical specialties to provide insightful coverage of the latest developments in the field. Mohit's work has been featured in Yahoo Finance, Zenger News, and Benzinga, as well as Yahoo Finance UK.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
Not enough data
Not enough data
Mohit Manghnani's coverage demonstrates a focus on technology, business, and oil & gas industries. He pays particular attention to legal and compliance issues within these sectors.
Given the prevalence of press releases in his articles, Mohit may be interested in receiving pitches related to significant corporate announcements or regulatory changes within the technology, business, and oil & gas sectors. This could include new product launches, major partnerships or acquisitions, or shifts in industry regulations.
Pitches providing expert analysis on legal and compliance matters impacting the mentioned industries might also resonate well with Mohit based on his coverage attributes.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Mohit Manghnani
SCNX Scienture Holdings, Inc. (NASDAQ: SCNX ) announced on Wednesday the formalization of multiple commercial group purchasing
3 min read In this article Coinbase Global, Inc. (NASDAQ: COIN ) is a leading digital asset exchange with $404 billion in assets on the platform and 8.4 million monthly transacting users as of fiscal year 2024.
Coinbase (COIN) is a leading digital asset exchange with $404B in assets and 8.4M monthly users. BTIG initiates coverage with Buy rating.
By: Mohit Manghnani
Co-Diagnostics, Inc. (NASDAQ: CODX ) announced on Monday that it has entered into a joint venture agreement with the Kingdom of Saudi Arabia (KSA) based Arabian Eagle Manufacturing
By: Mohit Manghnani
Investor optimism fuels stock market with strong earnings and projections from tech sectors like semiconductors, AI, and cloud computing.
By: Mohit Manghnani
Economic uncertainty and shifting market dynamics have recently heightened investor sensitivity, leading to notable fluctuations in stock prices.
Ford Motor Company (NYSE: F shares are up on Tuesday following a strong sales performance reported for 2025.
By: Mohit Manghnani
FibroBiologics Inc. (NASDAQ: FBLG) reports enrolling first patients in its Phase 1/2 trial for CYWC628, a fibroblast-based therapy targeting diabetic foot ulcers.
By: Mohit Manghnani
TransCode Therapeutics, Inc. (NASDAQ: RNAZ ) announced Wednesday that it has successfully completed the Phase 1a dose-escalation clinical trial of its lead cancer therapeutic candidate, TTX-MC138.
By: Mohit Manghnani
TransCode Therapeutics announced successful completion of Phase 1a clinical trial for TTX-MC138, showing safety and disease stabilization in patients with advanced cancer.
